山东药玻：目前公司中硼硅玻璃产品销售保持稳定

Core Viewpoint - The company is currently operating at near full capacity and has stable sales for its borosilicate glass products, with a positive outlook for export revenue growth in the coming years [2] Group 1: Production Capacity - The company's production lines are essentially at full capacity [2] - The pre-filled syringe project capacity will be gradually released based on equipment installation, debugging, and market conditions [2] Group 2: Sales and Revenue - Sales of borosilicate glass products are stable [2] - Export revenue is expected to grow year-on-year in the first three quarters of 2025 [2]